For patients and families

For patients and members of the patient's family, we have prepared this brochure. There are several sites in the US and Canada. Children with 22q11DS and symptoms of anxiety, inattention, and/or autism may be eligible. A brief outline of the study is provided in this leaflet. Click the button below to download a PDF describing the 22q11.2 trial.

Download patient brochure


For more information about participation in Nobias' trial in 22q11DS, contact the participating center closest to you.

United States, Pennsylvania
Children's Hospital of Philadelphia (CHOP)
Philadelphia, Pennsylvania, United States, 19104
Contact: Panigrahi (Pree) Pratishtha    703-687-7772    panigrahip@chop.edu  
       
United States, Washington
Seattle Children's Hospital
Seattle, Washington, United States, 98115
Contact: Maria Benitez-Cortez    206-987-6338    Maria.Benitez-Cortez@seattlechildrens.org        
United States, Colorado
Children's Hospital Colorado
Aurora, Colorado, United States, 
Contact: Kiaira Coles    720-777-1497    kiaira.coles@childrenscolorado.org
‍
Canada, Ontario
The Hospital for Sick Children (SickKids)
Toronto, Ontario, Canada, M5G1X8
Contact: Keshini Devakandan    (416) 813-7654    keshini.devakandan@sickkids.ca        


Additionally, for more information about participating in clinical trials go to: https://clinicaltrials.gov/ct2/about-studies/learn

For more information about Nobias' trial in 22q11DS go to: https://clinicaltrials.gov/ct2/show/NCT05290493?term=nb-001-01&draw=2&rank=1

For medical professionals

This brochure describes how to enroll your eligible patients and how the trial has been designed. Click the button below to download a PDF describing the 22q11.2 trial for medical professionals.

Download medical brochure